Geode Capital Management
BCYC

Geode Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Geode Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Hold
25,129
– – ﹤0.01% 4094
2025
Q4 		$178K Sell
25,129
-14,796
-37% -$109K ﹤0.01% 3946
2025
Q3 		$309K Sell
39,925
-487
-1% -$3.68K ﹤0.01% 3790
2025
Q2 		$281K Buy
40,412
+19,035
+89% +$152K ﹤0.01% 3762
2025
Q1 		$181K Sell
21,377
-17,438
-45% -$205K ﹤0.01% 3877
2024
Q4 		$543K Buy
38,815
+480
+1% +$10.3K ﹤0.01% 3573
2024
Q3 		$868K Buy
38,335
+16,958
+79% +$391K ﹤0.01% 3405
2024
Q2 		$433K Hold
21,377
– – ﹤0.01% 3619
2024
Q1 		$532K Buy
21,377
+2,540
+13% +$54K ﹤0.01% 3591
2023
Q4 		$341K Buy
18,837
+1,693
+10% +$28K ﹤0.01% 3748
2023
Q3 		$344K Hold
17,144
– – ﹤0.01% 3758
2023
Q2 		$438K Hold
17,144
– – ﹤0.01% 3695
2023
Q1 		$365K Hold
17,144
– – ﹤0.01% 3776
2022
Q4 		$507K Sell
17,144
-4,276
-20% -$115K ﹤0.01% 3652
2022
Q3 		$498K Buy
21,420
+10,287
+92% +$245K ﹤0.01% 3728
2022
Q2 		$186K Hold
11,133
– – ﹤0.01% 4308
2022
Q1 		$488K Buy
11,133
+1,253
+13% +$58.5K ﹤0.01% 3944
2021
Q4 		$601K Hold
9,880
– – ﹤0.01% 3947
2021
Q3 		$410K Buy
9,880
+2,401
+32% +$84K ﹤0.01% 4126
2021
Q2 		$227K Buy
+7,479
New +$226K ﹤0.01% 4293

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management's BCYC Position: Q1 2026 in Review

Geode Capital Management held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 25,129 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #4094.

Geode Capital Management first reported a position in BCYC in Q2 2021 and has held it in 20 quarters since. The position peaked at $868K in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Geode Capital Management held 25,129 shares of Bicycle Therapeutics worth $117K as of Q1 2026.
  • Geode Capital Management left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4094 holding.
  • Geode Capital Management first reported a position in Bicycle Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Bicycle Therapeutics position peaked at $868K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.